Plans are on hold for a state historical marker at the Alamo to honor early “Anglo American lawyers.” The State Bar of Texas has clearance from the Texas Historical Commission and Bexar County ...
Prostate-specific antigen (PSA) progression-free survival (PFS): A comparison of degarelix versus leuprolide in patients with prostate cancer. Background: Prostate cancer (PCa) is the second leading ...
Phase I trial of gene-mediated cytotoxic immunotherapy combined with resection for pancreatic adenocarcinoma. Background: Ki-67 is the major proliferative marker in clinical use to determine ...
HOUSTON, May 19, 2025 (GLOBE NEWSWIRE) -- MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback